• 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 88 Shown
  • Weighing Boosted vs Unboosted Options for a Patient With Comorbidities Who Desires an STR

    Eric S. Daar MD - 6/21/2017
    What is the optimal ART regimen for a patient with CKD and CVD who desires an STR?
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017 1 comment / Last Comment: 6/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?
  • Video Module cme-icon ce-icon

    Panel Discussion of Challenging Patient Cases in HIV

    Led by Kathleen E. Squires, MD, a panel of experts discusses their approach to management and prevention of HIV infection in complex clinical scenarios.
    Faculty: Joseph J. Eron, Jr. MD, Monica Gandhi MD, MPH, W. David Hardy MD, Kathleen E. Squires MD
    Released: 5/1/2017
  • Video Module cme-icon ce-icon

    Current Controversies in HIV Management

    Led by Joseph J. Eron, Jr., MD, a panel of experts discusses how they approach current controversies related to the management of patients with HIV infection.
    Faculty: Monica Gandhi MD, MPH, Joel E. Gallant MD, MPH, Kathleen E. Squires MD, Joseph J. Eron, Jr. MD, W. David Hardy MD, Kristen Marks MD
    Released: 5/1/2017
  • Learning Module cme-icon ce-icon

    CCO Independent Conference Coverage: Clinical Impact of New Data From CROI 2017

    In this Expert Analysis, Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, provide an in-depth discussion of the most clinically relevant new data on the management of patients with HIV infection presented at CROI 2017.
    Faculty: Joel E. Gallant MD, MPH, Charles B. Hicks MD
    Released: 4/27/2017
  • Contemporary Management of HIV: New Data From CROI 2017

    In this downloadable slideset, Charles B. Hicks, MD, and Program Director Joseph J. Eron, Jr., MD, review key new HIV data presented at the Seattle 2017 meeting.

    Topics include:
    -New data on currently available ART
    -Switch/simplification strategies for virologically suppressed patients
    -Investigational ARV agents
    -Treatment complications and comorbidities
    Date Posted: 4/26/2017
  • Contemporary Management of HIV: Management of HIV in Women

    In this downloadable slideset, Kathleen E. Squires, MD, and Program Director Joseph J. Eron, Jr., MD, review key data and optimal strategies in caring for HIV-infected women, including ART safety and efficacy in women, reproductive health management, ART and pregnancy, and preventing HIV infection in women.
    Date Posted: 4/25/2017
  • Avoiding Drug Interactions Among Hormonal Oral Contraceptives and ARVs

    Kathleen E. Squires MD - 4/10/2017
    Which ARV classes best avoid DDIs with hormonal contraception?
  • My Take on CROI Data Evaluating CNS Effects With INSTIs

    Joel E. Gallant MD, MPH - 4/5/2017 2 comments / Last Comment: 4/27/2017
    Recent data highlighting the potential for CNS effects with newer INSTIs has given me a sense of déjà vu about how we once approached the same issue with efavirenz. Here’s my take on what we know and how to proceed.
10 of 88 Shown
Show 10 More